14-104714228-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_022489.4(INF2):​c.3066T>C​(p.Asp1022Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.772 in 1,556,818 control chromosomes in the GnomAD database, including 465,065 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.80 ( 48839 hom., cov: 34)
Exomes 𝑓: 0.77 ( 416226 hom. )

Consequence

INF2
NM_022489.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -0.0870

Publications

21 publications found
Variant links:
Genes affected
INF2 (HGNC:23791): (inverted formin 2) This gene represents a member of the formin family of proteins. It is considered a diaphanous formin due to the presence of a diaphanous inhibitory domain located at the N-terminus of the encoded protein. Studies of a similar mouse protein indicate that the protein encoded by this locus may function in polymerization and depolymerization of actin filaments. Mutations at this locus have been associated with focal segmental glomerulosclerosis 5.[provided by RefSeq, Aug 2010]
INF2 Gene-Disease associations (from GenCC):
  • Charcot-Marie-Tooth disease dominant intermediate E
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, Labcorp Genetics (formerly Invitae)
  • focal segmental glomerulosclerosis 5
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • familial idiopathic steroid-resistant nephrotic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant 14-104714228-T-C is Benign according to our data. Variant chr14-104714228-T-C is described in ClinVar as Benign. ClinVar VariationId is 261613.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.087 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.908 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_022489.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
INF2
NM_022489.4
MANE Select
c.3066T>Cp.Asp1022Asp
synonymous
Exon 21 of 23NP_071934.3Q27J81-1
INF2
NM_001426862.1
c.3066T>Cp.Asp1022Asp
synonymous
Exon 21 of 23NP_001413791.1
INF2
NM_001426863.1
c.3066T>Cp.Asp1022Asp
synonymous
Exon 21 of 23NP_001413792.1Q27J81-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
INF2
ENST00000392634.9
TSL:5 MANE Select
c.3066T>Cp.Asp1022Asp
synonymous
Exon 21 of 23ENSP00000376410.4Q27J81-1
INF2
ENST00000617571.5
TSL:1
n.3062T>C
non_coding_transcript_exon
Exon 20 of 22ENSP00000483829.2A0A087X118
INF2
ENST00000675207.1
c.3162T>Cp.Asp1054Asp
synonymous
Exon 21 of 23ENSP00000502644.1A0A6Q8PHA2

Frequencies

GnomAD3 genomes
AF:
0.799
AC:
121428
AN:
152000
Hom.:
48799
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.867
Gnomad AMI
AF:
0.720
Gnomad AMR
AF:
0.833
Gnomad ASJ
AF:
0.794
Gnomad EAS
AF:
0.930
Gnomad SAS
AF:
0.735
Gnomad FIN
AF:
0.744
Gnomad MID
AF:
0.791
Gnomad NFE
AF:
0.753
Gnomad OTH
AF:
0.820
GnomAD2 exomes
AF:
0.787
AC:
142897
AN:
181548
AF XY:
0.778
show subpopulations
Gnomad AFR exome
AF:
0.865
Gnomad AMR exome
AF:
0.850
Gnomad ASJ exome
AF:
0.800
Gnomad EAS exome
AF:
0.934
Gnomad FIN exome
AF:
0.722
Gnomad NFE exome
AF:
0.752
Gnomad OTH exome
AF:
0.776
GnomAD4 exome
AF:
0.769
AC:
1079694
AN:
1404700
Hom.:
416226
Cov.:
59
AF XY:
0.766
AC XY:
531282
AN XY:
693164
show subpopulations
African (AFR)
AF:
0.875
AC:
28283
AN:
32316
American (AMR)
AF:
0.848
AC:
33989
AN:
40068
Ashkenazi Jewish (ASJ)
AF:
0.800
AC:
18720
AN:
23388
East Asian (EAS)
AF:
0.922
AC:
34654
AN:
37600
South Asian (SAS)
AF:
0.735
AC:
56606
AN:
77012
European-Finnish (FIN)
AF:
0.735
AC:
33289
AN:
45288
Middle Eastern (MID)
AF:
0.777
AC:
4353
AN:
5600
European-Non Finnish (NFE)
AF:
0.760
AC:
824383
AN:
1085220
Other (OTH)
AF:
0.780
AC:
45417
AN:
58208
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
13560
27120
40681
54241
67801
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20256
40512
60768
81024
101280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.799
AC:
121523
AN:
152118
Hom.:
48839
Cov.:
34
AF XY:
0.799
AC XY:
59386
AN XY:
74342
show subpopulations
African (AFR)
AF:
0.867
AC:
35989
AN:
41498
American (AMR)
AF:
0.833
AC:
12745
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.794
AC:
2755
AN:
3470
East Asian (EAS)
AF:
0.930
AC:
4808
AN:
5172
South Asian (SAS)
AF:
0.734
AC:
3536
AN:
4818
European-Finnish (FIN)
AF:
0.744
AC:
7874
AN:
10590
Middle Eastern (MID)
AF:
0.799
AC:
235
AN:
294
European-Non Finnish (NFE)
AF:
0.753
AC:
51196
AN:
67962
Other (OTH)
AF:
0.819
AC:
1728
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1272
2544
3815
5087
6359
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
868
1736
2604
3472
4340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.771
Hom.:
15438
Bravo
AF:
0.813
Asia WGS
AF:
0.852
AC:
2961
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not specified (6)
-
-
2
not provided (2)
-
-
1
Charcot-Marie-Tooth disease dominant intermediate E (1)
-
-
1
Focal segmental glomerulosclerosis 5 (1)
-
-
1
Focal segmental glomerulosclerosis 5;C4302667:Charcot-Marie-Tooth disease dominant intermediate E (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
1.1
DANN
Benign
0.33
PhyloP100
-0.087
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4983535; hg19: chr14-105180565; COSMIC: COSV53036802; COSMIC: COSV53036802; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.